You may not see your child as much as you are currently accustomed
In a 4-week controlled trial of VYVANSE in pediatric patients ages 13 to 17 years, mean weight loss from baseline to endpoint was -2.7, -4.3, and -4.8 lbs., respectively, for patients receiving 30 mg, 50 mg, and 70 mg of VYVANSE, compared to a 2.0 pound weight gain for patients receiving placebo
Retatrutide, in clinical trials, is administered via subcutaneous injection, typically once weekly, with doses ranging from 0.5 mg to 12 mg
When the normal digestive timing is altered, it may affect how the intestines process food components
If you are in Miramar, FL, and considering Tirzepatide, this guide will help you find the best providers and understand how this treatment works
DUPIXENT can cause allergic reactions, including skin reactions, that can sometimes be severe